Epic Sciences ( Epic Sciences )

Epic Sciences

Epic Sciences's picture

About Epic Sciences

Epic Sciences Inc. is a privately held biotech company that is developing highly sensitive diagnostic tests to molecularly characterize circulating tumor cells (CTCs) in the blood. We provide a better way to detect cancer and the ability to personalize and monitor cancer treatments.

Epic Sciences press release, blog etc

11/04/2018 - 19:19 Epic Sciences Joins Forces with Canadian Consortium of Investigators to Predict Late Recurrence of Metastatic Breast Cancer
10/29/2018 - 13:52 Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX AR-V7 Nucleus Detect Test in Patients with Metastatic Castrate Resistant Prostate Cancer, Effective
09/23/2018 - 19:34 Epic Sciences Announces Publication Showing Blood Test Could Help Select Metastatic Prostate Cancer Patients Who Respond to PSMA-Targeted Therapies
09/11/2018 - 23:34 Epic Sciences Announces Completion of $52 Million Series E Financing
09/04/2018 - 18:42 Epic Sciences Appoints Katherine Atkinson as Chief Commercial Officer
06/28/2018 - 15:31 Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer
05/22/2018 - 03:33 Epic Sciences Presents Single Cell Genomics Data at 10th DIA China Annual Meeting
05/16/2018 - 13:42 Epic Sciences and Its Collaborators to Present New Data at ASCO 2018
02/08/2018 - 07:27 Epic Sciences to Present Single Cell PSMA Analysis to Provide Insight into Tumor Heterogeneity and Links to Response with Anti-PSMA Therapy
01/04/2018 - 13:04 Epic Sciences to Present at the 2nd Annual CTIC Capital Cross-Border China-US Healthcare Investment Summit. Epic Sciences is one of six select companies chosen to present
01/04/2018 - 10:34 Epic Sciences to Present at the 2nd Annual CTIC Capital Cross-Border China-US Healthcare Investment Summit.
01/04/2018 - 06:13 Epic Sciences to Present at the 2nd Annual CTIC Capital Cross-Border China-US Healthcare Investment Summit
11/30/2017 - 12:09 Epic Sciences launches metastatic breast cancer circulating tumor cell panel.
11/30/2017 - 04:37 Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
11/02/2017 - 10:36 Epic Sciences launches single-cell microsatellite and chromosomal instability genomic analysis.
11/02/2017 - 04:11 Epic Sciences Launches Single-Cell Microsatellite and Chromosomal Instability Genomic Analysis
10/13/2017 - 09:20 Liquid biopsy test identifies androgen receptor protein expression in circulating tumor cells in women with metastatic breast cancer.
10/13/2017 - 06:45 Liquid Biopsy Test Identifies Androgen Receptor Protein Expression in Circulating Tumor Cells in Women with Metastatic Breast Cancer